DKSH has signed a strategic agreement with Curiox Biosystems to promote their cell washing technology in key Asian markets. This partnership is in line with the strategic focus of DKSH Business Unit Technology to solidify its position as a leading integrated solutions provider for the Scientific Instrumentation market.
Switzerland, October 28, 2021 – DKSH Business Unit Technology has entered into an exclusive partnership with Curiox Biosystems, an innovative manufacturer of cellular preparation equipment, headquartered in Seoul, South Korea. DKSH will provide sales and marketing, distribution and after-sales services support in markets across Asia, including Australia, New Zealand, Singapore and Thailand.
Curiox Biosystems has developed Laminar Wash™ technology, a suite of systems used for washing and preparing precious cells for flow cytometry and single cell sequencing applications. Faster and automatable, Laminar Wash systems streamline workflows, increase cell retention and generate more robust, reproducible data. DKSH will help distribute the products in industries like life science biotech, biopharma, academia and research.
“DKSH is a reliable partner in life sciences and has unique regional coverage to help us gain access to South East Asia and ANZ. We are convinced that DKSH is the right partner to help us expand our coverage and meet our aggressive growth goals,” said Namyong Kim, Ph.D., CEO of Curiox Biosystems.
Marco Farina, Senior Director, Business Development, Scientific Instrumentation, DKSH commented: “The partnership with Curiox Biosystems will help us grow as a dominant player in the growing cell analysis market with strong total solution offerings. We are confident to grow the market leveraging our knowledge through our Center of Excellence, extensive sales coverage, strong application support and world class post-sales services.”
For further information, please contact:
DKSH Business Unit Technology
Irene Chen Director, Group Marketing
Phone +886 2 8752 7611